<DOC>
	<DOC>NCT00900237</DOC>
	<brief_summary>This purpose of this study is to measure the concentrations of two anti-epileptic drugs (Eslicarbazepine acetate and oxcarbazepine) and their metabolites in the cerebrospinal fluid and blood plasma of healthy subjects and also to assess how these drugs are tolerated.</brief_summary>
	<brief_title>Study to Evaluate Pharmacokinetics and Tolerability of Multiple Doses of Eslicarbazepine Acetate and Oxcarbazepine</brief_title>
	<detailed_description />
	<mesh_term>Epilepsy</mesh_term>
	<mesh_term>Epilepsies, Partial</mesh_term>
	<mesh_term>Eslicarbazepine acetate</mesh_term>
	<mesh_term>Oxcarbazepine</mesh_term>
	<mesh_term>Carbamazepine</mesh_term>
	<criteria>Healthy subjects Aged 1855 years Body mass index (18.529 kg/m3)</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>Partial</keyword>
	<keyword>Epilepsy</keyword>
	<keyword>Eslicarbazepine acetate</keyword>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Tolerability</keyword>
</DOC>